my.chemeurope.com
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
Dr. Paul Lohmann® is a medium-sized, owner-managed manufacturer and developer of mineral salts based in Emmerthal The product portfolio comprises over 400 different Salts, from Aluminium to Zinc, in a total of over 7,000 different specifications. Dr. Paul Lohmann® supplies its special salts to custo more
PTS was founded in 1991 an through the years it has made a name for itself by organizing vocational training courses mainly concerning the topics GMP, GCP and GLP. Last year more than 80 courses took place with a total of 2000 participants coming from pharmaceutical, active pharmaceutical ingredient more
Central Glass Germany is dedicated to process development, upscaling and production of active ingredients and intermediates for the pharmaceutical and cosmetics industry. It operates a FDA and EU inspected facility in Halle-Kuensebeck. An experienced and highly skilled team of organic chemists and s more
One-stop source of information relating to the industrial synthesis and commercial applications of every licensed drug of significance more
Chirality is a fundamental property of many organic molecules and means that chemical compounds can appear in not only one form, but in two mirror-image forms as well. Chemists at Martin Luther University Halle-Wittenberg have now found a way to spontaneously induce chirality in crystalline, liquid- more
UZH researchers have developed a novel method that speeds up the process of determining crystal structures of organic salts and significantly reduces the effort required to do so. As about 40 percent of all active pharmaceutical ingredients are salts, this new crystallographic method is set to great more
With effect from 1st March 2017, Biesterfeld International will strengthen its business activities in France and show its presence in the country. Sales activities will be expanded and strategically developed in a focused process from the existing Biesterfeld Group location in Rueil-Malmaison, Paris more
Microcapsules contain and protect their core materials against reactions with the environment, then release this material deliberately at more
Reversible encapsulation of liquid materials is a technical challenge in many applications as for the transport and controlled delivery of active ingredients. In contrast to most state-of-the-art processes, capillary adsorbed solid particles can achieve a chemical-reaction-free encapsulation by form more
Molecules, Vol. 23, Pages 1305: Separation and Quantification of Four Main Chiral Glucosinolates in Radix Isatidis and Its Granules Using High-Performance Liquid Chromatography/Diode Array Detector Coupled with Circular Dichroism Detection Molecules doi: 10.3390/molecules23061305 Authors: Y more
Sustainability, Vol. 10, Pages 1784: Effectiveness of Fungicide on Soybean Rust in the Southeastern United States: A Meta-Analysis Sustainability doi: 10.3390/su10061784 Authors: Mary Delaney Althea A. ArchMiller Dennis P. Delaney Alan E. Wilson Edward J. Sikora Soybean rust ( more
Coupling biological molecules to surfaces, and using them in this form for measurement procedures, for analysis and in production processes, is a novel approach that is gaining increasing importance in industrial applications. Using established procedures, surfaces and biological molecules are produced separately from each other and are then recombined using complex technological procedures. more
New drugs are developed, among other reasons, with the aim of reducing dosage and having more targeted active ingredients. For patients, this development is definitely beneficial. These ingredients are described as highly potent active ingredients. But what does highly potent mean? And how are these substances handled in production, and what checks are performed to ensure the personnel are protected? more
Medical progress is facing a crisis: the significant investments into the development of new therapies in recent years have not resulted in an increase in approvals of innovative drugs. The number of newly launched medications has already been stagnating for some time, although pharmaceutical industry investments into research and development have multiplied. more
Read what you need to know about our industry portal chemeurope.com.
© 1997-2020 LUMITOS AG, All rights reserved
